October 7, 2026, 13:00-14:00
Zoom session
Reprocessing of medical devices and key quality standards
Registration closed
Delphine Perréard, University Hospital Geneva
Marie-Céline Zanella, University Hospital Geneva
Moderation:
Laurence Senn, CHUV Lausanne
October 1, 2026; 12:15-13:00
Zoom session
Rapid Blood Culture PCR Panels: Promise, Practice, and Clinical Impact
David Weller, University Hospital Zürich
12:00 - 12:45
Zoom session
Optimizing S. aureus treatment - Learnings from the SNAP trial
Registration closed
72 participants
Montreux Conference centre
Room Agora 1-4
13:00 - 17:00
Infections in the immunocompromised host/ Fungal infections /Fever of unknown origin
Coordination: Philipp Kohler, Cantonal Hospital St. Gallen
Nicolas Müller, University Hospital Zürich
Registration closed
Latifi B: Infections in neutropenic patients; case presentation
Scherz V: Infections in neutropenic patients; overview
Köhn F: Antibacterial prophylaxis with quinolones: yes or no?
Giannini A: Universal prophylaxis vs. pre-emptive approach against fungal infections
Vouloagka A: Discontinuation of antibiotic therapy: Can antibiotics be stopped in a neutropenic patient under some circumstances?
Staiger W: Infections in solid organ transplant recipients; case presentation
Lippmann J: Infections in solid organ transplant recipients; overview
Wettstein S: Asymptomatic bacteriuria in kidney transplant recipients: to treat or not?
Tallon de Lara C: CMV management: prophylaxis vs. preemptive approach
Schumacher M: Secondary prophylaxis against PJP after first episode: yes or no? If yes, how long?
Bellini P: Fever of unknown origin; case presentation
Simon N: Fever of unknown origin; structured approach
Friedrich B: Is there still a role for patient history in FUO?
Ruiz Arabi E: Should a PET-CT scan be performed as first line radiological diagnostic step
Mertelsmann A: What is the role of AI in the diagnostic process?
Latifi B: Infections in neutropenic patients; case presentation
Scherz V: Infections in neutropenic patients; overview
Köhn F: Antibacterial prophylaxis with quinolones: yes or no?
Giannini A: Universal prophylaxis vs. pre-emptive approach against fungal infections
Staiger W: Infections in solid organ transplant recipients; case presentation
Lippmann J: Infections in solid organ transplant recipients; overview
Wettstein S: Asymptomatic bacteriuria in kidney transplant recipients: to treat or not?
Tallon de Lara C: CMV management: prophylaxis vs. preemptive approach
Schumacher M: Secondary prophylaxis against PJP after first episode: yes or no? If yes, how long?
Bellini P: Fever of unknown origin; case presentation
Simon N: Fever of unknown origin; structured approach
Friedrich B: Is there still a role for patient history in FUO?
Ruiz Arabi E: Should a PET-CT scan be performed as first line radiological diagnostic step
Mertelsmann A: What is the role of AI in the diagnostic process?
Montreux Music Convention Centre
September 9, 2026; 17:15 - 18:15
Registration via SSI Annual meeting
Paredes R: The gut microbiome in HIV treatment and cure
Low N.: Mpox in Switzerland: how did we get from IIb to Ib?
September 2, 2026, 13:00-14:00
Zoom session
Implementation and Communication Sciences in IPC
Registration closed
Lauren Clack, University of Zurich
Moderation:
Laurence Senn, CHUV Lausanne
12:00 - 12:45
Zoom session
98 participants
Molecular Syndromic Testing in Infectious Disease - When Does Faster Actually Mean Better?
Registration closed
Speaker: Silvio Brugger, University Hospital Zurich
Moderator: Pauline Vetter, University Hospital Geneva
July 8, 2026, 13:00-14:00
Zoom session
Control of the hospital environment, including requirements for air quality, water, and surface maintenance
Registration closed
Dominique Blanc, CHUV Lausanne
Moderation:
Niccolò Buetti, University Hospital Geneva
12:00-12:45
Zoom session
70 participants
MDR Gram negatives: an insight from bed to bench and back
Registration closed
Speakers and moderators
Baharak Babouee Flury, Cantonal Hospital St. Gallen
Diego Andrey, University Hospital Geneva
17:10 - 17:55
Zoom session
Shorter is better
Registration closed
Speaker: Brad Spellberg, Los Angeles General Medical Center, USA
Moderator: Philipp Jent, Inselspital Berne
June 10, 2026, 13:00-14:00
Zoom session
Health policy and legal aspects
Registration closed
Delphine Berthod, Hôpitaux du Valais
Gaud Catho, Hôpitaux du Valais
Benedikt Wiggli, Cantonal Hospital Baden
Moderation:
Laurence Senn, CHUV Lausanne
June 4, 2026; 12:15-13:00
Zoom session
Antibiotics in palliative/End-of-Life situations
Registration closed
Speaker: Blerina Latifi, Inselspital Bern
Moderator: Eloïse Magnenat, Inselspital Bern
3 juin 2025, 14:00-17:00
Hôtel Royal, Rue de Lausanne 41, 1201 Genève
Programme provisoire, du 14 avril 2026
Inscription fermée
May 21, 2026; 12:00 - 12:45
Zoom session
160 participants
New: Update on Hanta virus
Registration closed
Speakers
Pauline Vetter, Geneva University Hospital
Walter Zingg, Zürich University Hospital
Moderator: Dionysios Neofytos, Geneva University Hospital
May 13, 2026, 13:00-14:00
Zoom session
Prevention strategies and surveillance elements for HAI: nv-HAP, SSI, and viral infections
Registration closed
Delphine Berthod, Hôpitaux du Valais
Aline Wolfensberger, University Hospital Zurich
Moderation:
Laurence Senn, CHUV Lausanne
13:30-16:30
Inselspital Bern
Auditorium Maurice E. Müller
Freiburgstrasse 16, 3010 Bern
Hybride Veranstaltung
Programm, Status 23. April 2026
Registrierung geschlossen
Colin E.: Update Epidemiologie: Globale Trends – lokale Herausforderungen
Damonti L.: CRAB Ausbruch auf der Intensivstation – Lektionen für die Zukunft
Frick W., Bishtawi D.: Herausforderungen in Reinigung und Desinfektion, Inputreferat
Mutters N.: Herausforderungen der Infektionsprävention: Deutschland
Zingg W.: Herausforderungen der Infektionsprävention: Schweiz
Tschudin Sutter S.: Publikationshighlight Infektionsprävention
Colin E.: Update Epidemiologie: Globale Trends – lokale Herausforderungen
Damonti L.: CRAB Ausbruch auf der Intensivstation – Lektionen für die Zukunft
Frick W., Bishtawi D.: Herausforderungen in Reinigung und Desinfektion, Inputreferat
Mutters N.: Herausforderungen der Infektionsprävention: Deutschland
Zingg W.: Herausforderungen der Infektionsprävention: Schweiz
Tschudin Sutter S.: Publikationshighlight Infektionsprävention
Wednesday, 22nd April 2026, 13:30-17:45
Hybrid event
Auditoire Jequier Doge, CHUV
Rue de Bugnon 44, 1011 Lausanne
Métro CHUV
Programme, mise-à-jour 3 mars 2026
Registration closed
Davis J: The SNAP example: Platform adaptive trial designs
Huttner A: Why do we need clinical trials in Switzerland? Investigator perspective
Nagy Bonnard L: Why do we need clinical trials in Switzerland? Patients' perspective
Speich B: Switzerland: a country of cohorts – The TWICS opportunity
Tan R: Cluster randomized controlled trials: advantages and caveats
Lassen M: The power of routine data: conducting the mega-Danish clinical trial
Keitel K: Pragmatic clinical trial in low resource settings
Bielicki J: Large consortia in clinical trials: Opportunities and challenges
Davis J: The SNAP example: Platform adaptive trial designs
Huttner A: Why do we need clinical trials in Switzerland? Investigator perspective
Nagy Bonnard L: Why do we need clinical trials in Switzerland? Patients' perspective
Speich B: Switzerland: a country of cohorts – The TWICS opportunity
Tan R: Cluster randomized controlled trials: advantages and caveats
Lassen M: The power of routine data: conducting the mega-Danish clinical trial
Keitel K: Pragmatic clinical trial in low resource settings
Bielicki J: Large consortia in clinical trials: Opportunities and challenges
SSI session
April 16, 2026; 12:00 - 12:45
Zoom session
111 participants
NTM challenges: From guidance to practice
Registration closed
Speakers: Johannes Nemeth, University Hospital Zurich
Marisa Kälin, University Hospital Zurich
Moderator: Lucas Boeck, University Hospital Basel
9 April 2026; 17:00-17:45
Grosser Hörsaal Pathologie PATH D 22, Schmelzbergstrasse 12, 8091
Zürich; Universitätsspital Zürich
Hybrid event, Teams
Famous and obscure trolls of CAR-T cell therapies
April 8, 2026, 13:00-14:00
Zoom session
Concepts, prevention strategies, and surveillance elements for healthcare-associated infections (HAI): CLABSI, VAP, and CAUTI
Registration closed
73 participants
Niccolò Buetti, University Hospital Geneva
Andrea Büchler, CHUV Lausanne
Walter Zingg, University Hospital Zurich
Moderation:
Niccolò Buetti, University Hospital Geneva
March 19, 2026; 12:00 - 12:45
Zoom
127 participants
Sepsis Management: The beginning of the end or the end of the beginning
Registration closed
12 March 2026; 17:00-17:45
Grosser Hörsaal Pathologie PATH D 22, Schmelzbergstrasse 12, 8091
Zürich; Universitätsspital Zürich
Hybrid event, Teams
Towards a microbial blood biomarker of tuberculosis
March 11, 2026, 13:00-14:00
Zoom session
Epidemic management
Registration closed
65 participants
Gaud Catho, Hôpitaux du Valais
Lauro Damonti, Inselspital Berne
Moderation:
Niccolò Buetti, University Hospital Geneva
March 5, 2026; 12:15-13:00
Zoom
ESBL-Producing Enterobacterales: Epidemiology, therapy, and the current evidence behind infection control measures
Registration closed
Speaker: Roberta di Nicola, University Hospital Basel
Moderator: Nadine Bernasconi, University Hospital Basel
Bern, Inselspital, SITEM
13:30-17:30h
Freiburgstrasse 3, 3010 Bern
Felix Frey Auditorium
Bone and joint infections/ Skin & soft tissue infection
Coordination: Eveline Hofmann, Inselspital;
Richard Alexander Kühl, University Hospital Basel
Registration closed
65 participants
Tamó R: Diagnosis and treatment of native joint infections
Török J: Diabetic foot infections: duration of antibiotic treatment after amputation
Brahier Th: Indications for surgery in vertebral osteomyelitis
Vouloagka A: Diagnostic criteria, classification and treatment of fracture-related infections
Pallanza M: DAIR in prosthetic joint infections: indications and risk factors for failure
Valente L: The role and evidence of rifampicin in prosthetic joint infections
Schumacher M: Are antibiotics “holidays” necessary before re-implantation in two-stage exchange of a prosthetic joint infection?
Gubser P: Which antibiotics penetrate well into the bone - what is the evidence?
Dörr T: Classification of skin and soft tissue infections and their risk factors
Bock L: Antibiotic treatment duration of skin and soft tissue infection
Turicchi G: How to prevent recurrent cellulitis
Calame A: The returning traveler with a skin ulcer on the leg
Tamó R: Diagnosis and treatment of native joint infections
Török J: Diabetic foot infections: duration of antibiotic treatment after amputation
Brahier Th: Indications for surgery in vertebral osteomyelitis
Vouloagka A: Diagnostic criteria, classification and treatment of fracture-related infections
Pallanza M: DAIR in prosthetic joint infections: indications and risk factors for failure
Valente L: The role and evidence of rifampicin in prosthetic joint infections
Gubser P: Which antibiotics penetrate well into the bone - what is the evidence?
Dörr T: Classification of skin and soft tissue infections and their risk factors
Bock L: Antibiotic treatment duration of skin and soft tissue infection
Turicchi G: How to prevent recurrent cellulitis
Calame A: The returning traveler with a skin ulcer on the leg
February 19, 2026; 12:00 - 12:45
71 participants
Hyperammonemia syndrome in immunocompromized individuals: epidemiology, treatment and prevention
Registration closed
February 11, 2026, 13:00-13:45
Zoom session
Strategies for preventing the spread of germs
Registration closed
80 participants
Mohamed Abbas, University Hospital Geneva
Davide Bosetti, University Hospital Geneva
Sarah Tschudin Sutter, University Hospital Basel
Moderation:
Laurence Senn, CHUV Lausanne
Niccolò Buetti, University Hospital Geneva
February 5, 2026; 12:15-13:00
Registration closed
Fellows' session: Infectious diseases perspectives on burn patients
Speakers & moderators:
Giacomo Stroffolini & Florian Tagini, CHUV Lausanne
Engelberg, Kursaal
Registration closed
154 participants
Programme, updated January 9, 2026
Muller-Durovic B: Metabolic targets in EBV-infection
Hale B: Interferon autoantibodies
Renner E: Inborn immunodeficiencies and invasive infections
Jeker L: Targeting CD45 to replace the hematopoietic system for HIV eradication?
Rooijakkers S: Antibody-based Therapies for Infectious Diseases
Berney M: Innovation in Tuberculosis Drug Discovery and Development
Kouyos R: Primer: Mathematical Models in Infectious Diseases
Opatowski L: Mathematical and Epidemiological Modeling of Antimicrobial Resistance Drivers
Perez L: Computational Vaccine Design
Mongiat M: Back to geography class
Berger Ch: Twins prematurely born due to an infection?
Baumgartner Ch: Decompensated Cirrhosis: The Unusual Suspects
Marinosci A: Encephalitis at sixty-five
Frater J: Can T-cells confer sustained HIV suppression after bNAb therapy
Rutishauser R: Eliciting effective immune responses against HIV rebound
Trkola A: Multi-specificity is a common trait of HIV-1 broad neutralizing capacity
Feldman M: Biogenesis of extracellular vesicles in human gut bacteria
Valvano M: Intracellular persistence
Ramsey M: One (or two) ways in which bacterial commensals may prevent disease
Alimonti A: Microorganisms in oncogenesis and anti-cancer immune responses
Wong T: Diet-mediated immunometabolic regulation promotes Klebsiella pneumoniae airway clearance
Julian T: From clinical settings to wastewater systems
Schünemann V: Tracing pathogens through time with ancient DNA
Muller-Durovic B: Metabolic targets in EBV-infection
Hale B: Interferon autoantibodies - slides not available
Renner E: Inborn immunodeficiencies and invasive infections
Jeker L: Targeting CD45 to replace the hematopoietic system for HIV eradication?
Rooijakkers S: Antibody-based Therapies for Infectious Diseases - slides not available
Berney M: Innovation in Tuberculosis Drug Discovery and Development - slides not available
Kouyos R: Primer: Mathematical Models in Infectious Diseases
Opatowski L: Mathematical and Epidemiological Modeling of Antimicrobial Resistance Drivers
Perez L: Computational Vaccine Design
Mongiat M: Back to geography class
Berger Ch: Twins prematurely born due to an infection?
Gauthiez E: Horse or zebra? - slides not available
Baumgartner Ch: Decompensated Cirrhosis: The Unusual Suspects - slides not available
Marinosci A: Encephalitis at sixty-five
Frater J: Can T-cells confer sustained HIV suppression after bNAb therapy
Rutishauser R: Eliciting effective immune responses against HIV rebound
Trkola A: Multi-specificity is a common trait of HIV-1 broad neutralizing capacity - slides not available
Feldman M: Biogenesis of extracellular vesicles in human gut bacteria
Valvano M: Intracellular persistence
Ramsey M: One (or two) ways in which bacterial commensals may prevent disease
Alimonti A: Microorganisms in oncogenesis and anti-cancer immune responses
Wong T: Diet-mediated immunometabolic regulation promotes Klebsiella pneumoniae airway clearance
Julian T: From clinical settings to wastewater systems
Schünemann V: Tracing pathogens through time with ancient DNA - contact secretary@safe-id.ch for slides
Virtual lunch session:
Tardoc
December 11, 2025; 12:00-12:45
Registration closed
107 participants
Tardoc
Barbara Hasse, University Hospital Zürich
Madeleine Rothen, Board member SSI